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Receptor of Advanced Glycation Endproducts (RAGE) is Positively Correlated 
with Tumor Necrosis Factor-α in Adolescents with Obesity
Tasnim Rahman1, and Daniel H. Conrad1 Ph.D, Anshu Gupta, 2* MD
1Department of Microbiology and Immunology, 2 Department of Pediatrics
Abstract
Introduction: Obesity in childhood is associated with an increased 
prevalence of diabetes and other traditional cardiometabolic risk factors, 
suggesting an epidemic of premature cardiovascular disease among today’s 
youth. Glycotoxins, known as advanced glycation end products (AGE’s), 
activating via the membrane-bound receptors (mRAGE), have been 
implicated in the pathophysiology of inflammation, (increased tumor necrosis 
factor- α [TNF- α ]), insulin resistance and vascular dysfunction in adults, but 
the role of RAGE in the early stages of metabolic disorders is unknown. In 
this study, we assessed relationship of cardiometabolic risk factors, mRNA 
expression of TNF- α and RAGE in peripheral monocytes in adolescents with 
obesity. 
Methods: Thirty three adolescents,11-16 years of age, with body mass 
index (BMI) Z-score≥2 were admitted following a 12-hour overnight fast for 
anthropometrics, lipid profile , fasting peripheral blood sample collection, and 
a 2-hour 75 gm, oral glucose tolerance test (OGTT). Peripheral blood 
mononuclear cells (PBMNC) positive for CD14 were isolated from blood. 
Cells were further analyzed by quantitative PCR for mRNA expression of 
RAGE and TNF-α. Pearson's coefficients were calculated to assess the 
associations between RAGE mRNA and cardiometabolic risk factors as well 
as TNF- α mRNA levels. 
Results: The participants had a mean age of 12.7±1.41 years and BMI-
Z score 2.32±0.35 SD with 81 % participants being female; 62 % were 
Black, 28% Caucasian, 10% were Hispanic.  We observed a positive 
correlation between mRNA levels of RAGE and TNF- α in CD14+ monocytes 
in blood (r=0.62, p<0.01). However, we did not observe a correlation of BMI, 
cholesterol or triglyceride with RAGE mRNA levels.
Conclusion:  The positive relationship between the monocyte mRNA 
levels of RAGE and TNF-α suggest involvement of AGE- RAGE axis in 
obesity-associated inflammation and needs to be further investigated with 
larger sample size as well as studies in healthy adolescents.
Introduction
Receptor of Advanced Glycation End product is a signal transduction 
receptor associated with recognizing stress and inflammatory signals. It is a 
membrane bound recognition receptor that also works as a cell-adhesion 
molecule. RAGE is particularly involved in mediating pro-inflammatory 
actions of dietary glycotoxins known as Advance Glycation Endproducts
(AGEs). Escalated levels of AGE-RAGE have been associated with both 
types of diabetes ,obesity , metabolic syndrome  and a number of 
degenerative diseases.
RAGE is expressed mostly in monocytes/macrophage. RAGE is 
responsible for enhanced expression of a key pro-inflammatory cytokine 
tumor necrosis factor alpha (TNF-α) which has been associated with the 
regulation of adiposity and insulin sensitivity. Both RAGE + TNF-α have 
been shown to play vital roles in the development of metabolic syndrome, a 
morbid combination of obesity, insulin-resistance, diabetes and hypertension.
AGE binding followed by activation of RAGE has been linked to 
diabetes, cardiovascular disease and obesity in both human and mice models. 
Blocking RAGE has been shown to suppress atherosclerosis. Therefore we 
hypothesized that enhanced RAGE gene expression in monocytes will 
correlate with cardiometabolic risk factors including glucose, cholesterol and 
triglyceride levels in adolescents with obesity.
Conclusion
• The positive correlation between RAGE and TNF-α expression 
suggests that RAGE is linked to inflammatory factors such as 
TNF-α in adolescents with obesity.
• Based on data so far so we do not see a relationship of  RAGE 
gene expression with measures of obesity of dyslipidemia in our 
sample of adolescents with obesity. 
• To our knowledge this is the first time  expression of RAGE has 
been assessed in adolescents with obesity. However, it needs to be 
compared with RAGE expression in healthy adolescents. 
Therefore, we are recruiting for healthy adolescents and plan to 
compare the gene expression levels in the two groups.
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Figure 1: AGE-RAGE 
relationship in terms of 
Metabolic Syndrome 
Obese individuals are 
persistently in an 
inflammatory stage 
enhanced by AGE-RAGE 
binding, which 
consequently increases 
expression of pro-
inflammatory cytokines 
such as TNF-α and IL-1 
exacerbating metabolic 
syndromes 
Figure 2: CD14+ 
monocytes isolation 
using MACS Column
PBMC incubated with 
CD14 beads was washed 
and aspirated in MACS 
MS column. CD14+ 
cells were used for 
RAGE and TNF-α
expression by qPCR.
Figure 3 (LEFT): CD14+ flow 
through was analyzed for 
representative purity by Flow 
Cytometry (Diva Software V.8, BD 
Canto Flow Analyzer). A satisfactory 
purity of 85.76% validated success of 
PBMC isolation and MACS column 
aspiration. 
Figure 4 (BELOW): Correlation 
between % mRNA levels of RAGE 
and TNF-α in CD14+monocytes in 
blood. (r=0.62, p<0.01)
The cardiometabolic risk factors that were assessed with RAGE 
and TNF-α levels are BMI-Z score, cholesterol (LDL/HDL) and 
triglyceride levels. 
Participants had a mean age of 12.7±1.41 years and BMI-Z 
score 2.32±0.35 SD with 81 % participants being female; 62 % were 
Black, 28% Caucasian, 10% were Hispanic. 
%mRNA expression of RAGE and TNF-α were 31.06% and 
34.29% respectively. 
We saw a positive correlation (r=0.62, p<0.01) between RAGE 
and TNF-a expression.
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